Novel Association of Early Onset Hepatocellular Carcinoma with Transaldolase Deficiency
We evaluated a family with a 16-month-old boy with cirrhosis and hepatocellular carcinoma and his 30-month-old brother with cirrhosis. After failing to identify a diagnosis after routine metabolic evaluation, we utilized a combination of RNA-Seq and whole exome sequencing to identify a novel homozygous p.Ser171Phe Transaldolase (TALDO1) variant in the proband, his brother with cirrhosis, as well as a clinically asymptomatic older 8-year-old brother. Metabolite analysis and enzymatic testing of TALDO1 demonstrated elevated ribitol, sedoheptitol, and sedoheptulose-7P, and lack of activity of TALDO1 in the three children homozygous for the p.Ser171Phe mutation. Our findings expand the phenotype of transaldolase deficiency to include early onset hepatocellular carcinoma in humans and demonstrate that, even within the same family, individuals with the same homozygous mutation demonstrate a wide range of phenotypes.
KeywordsHepatocellular Carcinoma Exome Sequencing Glycogen Storage Disease Urine Organic Acid Normal Platelet Count
Birthe Roos and Erwin Jansen are kindly acknowledged for their analytical contributions.
- Eyaid W, Al Harbi T, Anazi S et al (Jan 12 2013) Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype. J Inherit Metab Dis (Epub ahead of print)Google Scholar
- Fung CW, Siu S, Mak C, Poon G et al (2007) A rare cause of hepatosplenomegaly-Transaldolase deficiency. J Inherit Metab Dis 30(Suppl 1):62Google Scholar
- Jansen G, Muskiet FA, Schierbeek H, Berger R, van der Slik W (1986) Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. Clin Chim Acta 157(3):277–293PubMedCrossRefGoogle Scholar